Trooperstocks
9月前
$BSGM News: Streamex Exchange Corp NASDAQ-BSGM Creates a Tokenized Yield-Bearing Gold Product Generating up-to 4% through Exclusive Partnership with Monetary Metals
BioSig Technologies, Inc.; Monetary Metals
Mon, September 8, 2025 at 10:10 AM EDT
Partnership unlocks exclusive tokenization rights, a four percent (4%) annual yield target on physical bullion, revenue share tied to leasing volumes and the creation of a groundbreaking institutionalized asset providing yield on physical gold holdings
Key Partnership Highlights
Streamex secures exclusive tokenization rights for yield-bearing gold products through Monetary Metals
Investors gain access to an estimated four percent (4%) annual yield through tokenized bullion assets and gold treasury
Strategic structure includes revenue share tied to gold leasing volumes on Monetary Metals’ platform
LOS ANGELES and SCOTTSDALE, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc., which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), together with Monetary Metals, a pioneer in gold and silver denominated financial products and strategies, today announced an exclusive long-term strategic partnership to launch a groundbreaking up to 4% yield generating gold product supported by Streamex’s tokenization and treasury platforms.
Through this collaboration, Streamex will gain exclusive rights to tokenize yield-bearing gold products while Monetary Metals provides access to its precious metals leasing and bond programs. Through the partnership, Streamex expects to offer investors an opportunity to earn an estimated four percent (4%) return on the tokenized gold bullion products that the Company will offer, as well as earning a return on the Company’s own gold treasury holdings.
“This collaboration represents a breakthrough in bridging the traditional gold market with digital assets,” said Henry McPhie, CEO of BioSig and Co-Founder of Streamex. “By earning yield on our gold holdings and creating tokenized yield products, we are building the foundation for scalable, institutional-grade instruments that can support billions of dollars in investment and unlock entirely new opportunities for investors.”
Under the agreement, Streamex will act as the exclusive tokenization partner of Monetary Metals for a minimum of three years, creating and distributing yield-bearing digital assets that combine the strength of physical bullion with the innovation of blockchain-based markets. Streamex will fund at least ten percent of the book of eligible Monetary Metals’ gold leases.
The agreement also provides Streamex with a revenue share tied to leasing volumes on Monetary Metals’ platform. This structure creates a mutually aligned model designed to scale significantly, institutionalizing yield-bearing bullion products backed by a comprehensive treasury strategy.
“Gold is a global, financial asset with deep liquidity. Paying fees to let it sit idle in a vault should not be the only option. Our vision has been to unlock gold’s natural utility by using it to finance real-world businesses and generate a yield,” said Keith Weiner, Founder and CEO of Monetary Metals. “We are excited to work with Streamex to create new ways to deliver gold yield to global markets, including tokenized solutions that combine the trust of gold with the accessibility of blockchain. This partnership is a major step on the road to gold reclaiming its place in global finance.”
About Streamex
Streamex is an RWA tokenization company building Institutional grade infrastructure to bring the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.
About Monetary Metals
Monetary Metals® is Unlocking the Productivity of Gold™ by offering a Yield on Gold, Paid in Gold® to investors, and Gold Financing, Simplified™ to gold-using businesses (mints, miners, refiners, jewelers, etc.). Since 2016, individuals and institutions around the world have been earning interest in gold and silver every month through its Gold Yield Marketplace®.
About BioSig Technologies
BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will realize the benefits of the agreement described in this press release in a timely manner or at all, whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.
Contacts
BioSig/Streamex Press & Investor Relations:
Adele Carey
Alliance Advisors Investor Relations
acarey@allianceadvisors.com
Ele Kauderer, Public Relations
Phoenix Management
PR@PhoenixMGMTconsulting.com
+1 888-228-0122
Henry McPhie
CEO of BioSig, Co-Founder of Streamex
contact@Streamex.com
https://www.streamex.com/
https://x.com/streamex
Monetary Metals Contact Information:
Dickson Buchanan Jr.
Vice President Marketing
dickson@monetary-metals.com
646-653-9729
For additional information or press inquiries, please contact press@monetary-metals.com
Trooperstocks
10月前
$BSGM News: BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the Securities and Exchange Commission (the “SEC”) on December 17, 2024. A final prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission, together with an accompanying base prospectus. The securities may be offered only by means of a written prospectus forming a part of the effective registration statement. Copies of the final prospectus supplement relating to the offering, together with the accompanying base prospectus, may be obtained, when available from the SEC’s website at http://www.sec.gov, from Clear Street, Attention: Syndicate, 4 World Trade Center, 150 Greenwich St, Floor 46, New York, NY 10007, or by email at syndicate@clearstreet.io and Needham & Company, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, prospectus @tekboy.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein. BioSig will not, and has been advised by the joint book-running managers that they and their affiliates will not, sell any of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Streamex
Streamex is a RWA and gold tokenization company building Institutional grade infrastructure to bring the gold market on chain, enabled by a gold denominated treasury and an institutional grade tokenization platform. Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.
About BioSig Technologies
BioSig Technologies, Inc. is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.
The PURE EP™ Platform enables electrophysiologists to acquire raw signal data in real-time—absent of unnecessary noise or interference—to maximize procedural success and minimize unnecessary inefficiencies. As physician advocates, we believe that the ability to maintain the integrity of intracardiac signals with precision and clarity without driving up procedural costs has never been more pertinent.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition and recently announced convertible debenture financing and standby equity purchase agreement will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled "Risk Factors" in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.
Press & Investor Relations:
Ele Kauderer
PR@PhoenixMGMTconsulting.com
+1 888-228-0122
Henry McPhie
CEO of BioSig, Co-Founder of Streamex
contact@Streamex.com
https://x.com/streamex
Trooperstocks
11月前
$BSGM News: Jul 14, 2025 5:00 AM Eastern Daylight Time
CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor
original
CORRECTION...by BioSig Technologies, Inc.
VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--Please replace the release dated July 11, 2025 with the following corrected version due to revisions to details of Russell Starr’s appointment and biography. During this period, Mr. Starr was not the Chief Executive Officer of the Company, but instead served as Head of Capital Markets Consultant at DeFi Technologies.
The updated release reads:
BIOSIG & STREAMEX APPOINT DEFI EXPERT AND VISIONARY, RUSSELL STARR AS STRATEGIC ADVISOR
BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across, defi, traditional finance and emerging sectors.
A former executive on Bay Street and respected entrepreneur and financier, Mr. Starr has built a reputation for navigating high-stakes financial transactions and guiding companies through complex growth trajectories. Most recently, he was Head of Capital Markets Consultant at DeFi Technologies, a publicly traded company at the forefront of decentralized finance and digital asset innovation. During his time with DeFi Technologies, it accelerated its strategic focus on Web3 infrastructure, emerging markets, and tokenized finance. Mr. Starr also helped bring DeFi Technologies to be listed on the Nasdaq.
Mr. Starr’s career is defined by a consistent focus on long-term value creation, particularly in the natural resource and renewable energy sectors. He is a strong advocate for Canada’s emerging leadership in the global resource economy and sees the convergence of the renewable energy transition and weakening fiat currencies as powerful tailwinds for real asset investment.
Over the course of his career, Mr. Starr has held key leadership roles across public and private companies, contributing deep expertise in M&A, venture capital, and strategic partnerships. His ability to structure high-return, high-impact deals has earned him the trust of stakeholders across sectors.
“Russell’s experience in capital markets, natural resources, and decentralized finance make him an exceptional addition to the Streamex advisory team,” said Henry McPhie, CEO of BioSig and Co-Founder of Streamex. “His visionary leadership and belief in the long-term value of real assets align perfectly with our mission to bring commodities on chain. We’re thrilled to welcome him as we scale our presence in the tokenized asset space.”
Mr. Starr commented, “Streamex is leading a powerful shift in how real-world assets are accessed, valued, and exchanged. The infrastructure they're building is unlocking the full potential of tokenized commodities. I'm excited to contribute to a platform that combines deep market knowledge with a bold, innovative vision.”
Streamex’s Advisory Board
Russell Starr joins a world-class group of strategic advisors at Streamex:
Frank Giustra – Strategic Investor and Advisor on Commodities
Founder of Wheaton Precious Metals ($37B)
Founder of GoldCorp (Acquired by Newmont for $57B)
Founder of LionsGate Films ($2B)
Sean Roosen – Strategic Advisor on Mining and Asset Strategy
Founder, Executive Chairman, and CEO of Osisko Development Corp.
Founder & Former CEO of Osisko Mining
Founder & Former CEO of Osisko Gold Royalties ($6.9B)
Mathew August – Strategic Advisor on US Capital Markets
Executive Chairman of Atlas Capital Partners, a New York-based single-family office and merchant bank
Active venture capitalist with investments in Defense Tech, FinTech, and Aerospace
Russell Starr – Strategic Advisor on Defi & Resource Innovation
Head of Capital Markets Consultant of DeFi Technologies
Veteran Bay Street executive and capital markets expert
Entrepreneur specializing in high-return transactions, renewable energy, and natural resources
Trevor Bacon – Strategic Advisor on DeFi Infrastructure
CEO and Co-Founder of Parcl
Former Portfolio Manager and Barclays Vice President
Kellan Grenier – Strategic Advisor on Tokenized Asset Strategy and Web3 Integration
COO and Co-Founder of Parcl
Former Investment Analyst and blockchain strategist
About Streamex
Streamex is a gold treasury and infrastructure company building the foundation for on-chain commodity markets. With a focus on real-world asset (RWA) tokenization, Streamex is developing a vertically integrated platform that combines token issuance, trading infrastructure, and physical gold holdings positioning the Company to become one of Nasdaq’s largest public holders of gold bullion.
This strategic approach aligns with Streamex’s mission to reshape global finance by bringing the approximately $142 trillion global commodities market on chain. By merging the security and trust of physical gold with the efficiency and transparency of blockchain, Streamex is creating scalable financial infrastructure for a new era of digital commodities.
The Company plans to hold significant quantities of physical gold, securely vaulted through a top-tier bullion bank. Streamex will denominate the majority of its balance sheet in vaulted gold rather than fiat currency, supporting a long-term, value-based financial model. Combined with Streamex’s Solana-based blockchain infrastructure, this strategy enables a recurring revenue model that supports the issuance of gold-backed digital assets.
Streamex is a wholly owned subsidiary of BioSig Technologies, Inc.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.
Contacts
johanna@trailrunnerint.com
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
MightyX
1年前
Monksdream
1年前
glenn1919
1年前
StockProUSA
1年前
メールアドレスで登録
